Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|July 20, 2011
c-Cbl and Cbl-b ligases mediate 17-allylaminodemethoxygeldanamycin-induced degradation of autophosphorylated Flt3 kinase with internal tandem duplication through the ubiquitin proteasome pathwayGaku Oshikawa, Toshikage Nagao, Nan Wu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Aggressive B-cell lymphoma with IGH/MYC, IGH/BCL2, and IGH/CCND1 translocations]Akihiko Nishijima, Yuma Noguchi, Kensuke Narukawa, et al.
Pathology Oncology Research : POR|July 4, 2013
Clinical outcome of hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL): experience from a single institutionNoriko Doki, Kazuteru Ohashi, Gaku Oshikawa, et al.
Clinical Case Reports|March 9, 2019
Acute promyelocytic leukemia presenting as recurrent spinal myeloid sarcomas 3 years before developing leukemia: A case report with review of literatureTomoko Yamashita, Akihiko Nishijima, Yuma Noguchi, et al.
Oncology Letters|July 12, 2017
Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case reportKeisuke Tanaka, Gaku Oshikawa, Hiroki Akiyama, et al.
Pathology Oncology Research : POR|April 8, 2014
The predictive value for pulmonary infection by area over the neutrophil curve (D-index) in patients who underwent reduced intensity hematopoietic stem cell transplantationJun Aoki, Masaharu Tsubokura, Kazuhiko Kakihana, et al.
Oncotarget|April 1, 2015
FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemiaAyako Nogami, Gaku Oshikawa, Keigo Okada, et al.
Plos One|January 10, 2014
Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia veraToshikage Nagao, Tetsuya Kurosu, Yoshihiro Umezawa, et al.
Oncotarget|June 22, 2018
Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2Shinya Ishida, Hiroki Akiyama, Yoshihiro Umezawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 22, 2006
[Bortezomib-induced tumor lysis syndrome with a remarkable elevation of LDH in a case of relapsed and therapy-resistant multiple myeloma]Ayako Arai, Gaku Oshikawa, Tetsuya Kurosu, et al.
Pageof 4